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Heart tr~~sp~a~tat~Q~ aEords a r,.., -=&r&able degree of reha- 
biiiiatior~ for paiienls with end-Stage heart faiiure and aI sf 
its attendant herdynamic abnormalities and functiona! 
limitzdions. in highly selected patients this silrgica! proce- 
dure is vastly superior 
. . ,. 
to other exlstmg rorsnS c!, ,,,,...p, -c *Lnra v in 
improving functional capacity and survival. Cardiac d- 
lografts, however, do {lot fufiction tot& normaily and 
exercise tdrra3ce In trar,spiant recipieiits is somewhat less 
than might be expected. It is important to understand the 
implications of the altered physiology of the denervated 
heart because of its re!aiion to exercise tolerance. physica! 
rehabilitation, postoperative coimplications dnd pharmaco- 
therapeutic intervention. 
Heart transplant recipients often ham severe psychoiogic 
djr;function caused by symptirms from their previous car- 
Tiie function d the orthotopically 
complicated interplay of ventricular lodding c 
trinsic myocardial contractile capability. circulati 
choiamine levels, denervation (with, in some cases, pa&! 
reinnervation), donor/recipient size relation, ~~~~~~~la~~ per- 
formance and atrial function. Table 1 summarizes many of 
the issues relevant to ffrnction of the transplantid heart. 
32 YOUNG ET AL. 
TASK FORCE 4 
YACC Vol. 22, NE. 1 
July 1993: l-64 
Table I. Factors Affecting: Function of the Transplanted Hedrt Hemodywmics in ~~~~~~s 
iiemodynamtc 
Donodrecipient bodjr size relation 
Donockecipieot atriai asynchrony 
Ear& postoperative restricdve &ysio!ogy 
Late postoperative restric’ive physiology 
Denervation 
AiYerent denervatior! 
Altered reflex control of periphal vasoconstrictionlvasodilation 
Altered Nat/H,0 regulation via central nervous system-dependent 
vasopressin, rer;in. angiotensin, aldosterone secretion 
Absence of angina! syndrome during &hernia 
Efferent tienervation 
Absent vagal nerve control 
Sapid heart rate at rest 
i .?lW!Cd l&ii~ iok X+ns? !O ererrisc 
Z:y$e-sensitivity to ctrcl;lzUing c:~!+:hc!aminf-c 
P Wed hormonal milieu 
I Arrkal natr:uretic pcptide secretion changed 
tievatcd tixercise circulating catecholamincb 
Myocardial injury/malatiaptation 
Orgn preservation/recovery injury 
Intraoperdtivc comyfications 
Rejection 
V:stricu!ar hypertropby 
Hypertension (increased ventricular wall stress) 
Allogrhft aiterlopathy tischemial 
-I__ . .._- 
Any evafcaiion of hiit trullaV roncn!ztnt physiology mast be 
considered ir? light of the fact that he implants are probably 
functioning f;tr more normally than the organs they replaced. 
Furthermore, these transplanted organs demonstrate FC!- 
markable, thotigh not entireiy normal, functiooai reserve. 
The first reports of heart ransplantation n humans provided 
some data regarding hemodynamics, but it has become clear 
that rejection plays an ~rn~c~~ailt role in confounding obser- 
vations in this regard. Early reports (12) suggested that 
cardiac output was usuaily depressed soon after tramsplan- 
tation and that ~tem~~ce of a hi pres- 
sure was esse re re- 
cently, atrial dynamics have hen-- --liJ UV\ #a SIU~_LU LU be abnormai (13). 
Because of the midatria! anastomosis between donor and 
recipient hearts, varying portions of donor and recipient 
atria are present, and the native atria do not contract 
synchronously with the altograft atria because native sinus 
node electrical activity ia not transmitled across the atria! 
suture iiiies. Consequent!;, less: than the expected 15% to 
20% dormai atriai conitribution to flet stroke volume is often 
noted. 
Initiai repoi is summarizing hemodynamic fo”iillow-up after 
heart transplantation (14.15) noted that iittracardiac pi-es- 
sures usuaily were normal at rest, bQt that ventricular 
diastolic pressure increased ramatically during exertion. 
Recent publications have focused on the evolutionary 
changes ifihemcdynamic pauc. “+*-;ns noted in patients receivicg 
a cyclofporine-&cd immunorhel.apeutic protocol (ii;--is). 
Cwiip!ica!ing factors, such as rejectiora and artGa? byper- 
tension, have been emphasized. A restrictive hemodynamic 
pattern has been documented early after heart transplanta- 
iio? that resolves within da:/s or weeks (19). Interestnngiy, a 
subclinical. iatcnt restrictive hemodynamic state may persist 
for much !onger, but may require volume challenge to 
unmask (18). The presence of persistently impaired ::~%-i n 
uiar filling iate after transpiantation (seen in 10% to 15% of 
patients) has been Mted to the incidence of graft rejection 
(20). Another expiaGation, that is, donor-recipi,:nt size mis- 
match, maji also account for the observatiorn of restrictive 
hemodynamic patterns. Donor siLe is often 20% to 30% less 
than that of the recipient. Hosenpud et al. (21) reported a
significant egative crtrre!ation between donor to re:cipient 
weight ratio and heart rate at rcsa +right atriai pressure and 
pulmonary capiirary wedge pressure 3 months after traas- 
pfantatiun. Patients rec;eivlng a heart from a donor weighing 
substantially less than the recipient had higher e~i vaiues for 
hear! rate and bcntricular filling pressures than that of other 
patients, 
Insighi ink hemodynamic characteristics of transplanted 
hearts lvas fire’ ’ _I ganed 5-m study of catiae models. Mann, 
et al. (1) suggested in 1933 that cardiac htciioG &r heart 
transplantation -would be excellent if the “biologic factors” 
now known to be tissue rejection causing organ demise could 
be identified and controlled. Autotransplantation models 
(complete cardiac excision with subsequent reimplantation) 
clarified the impact of cardioplegia. ischemia nd denerva.- 
tion on subsequent cardiac performance (2-5). immediately 
after autotranspiantation, right and !eft heart pressiires are 
elevated but gradually return to control evels. sometimes 
over severa! weeks (6.7). Likewise, exercise tolerance ap- 
preaches that of controi animals with time (4-h). 
Other observations have included the fact that dogs with 
&ii autotransplant have :fl~ ’ 3xad KWi Ihod voiumcj corn- 
pared with vmliues incontrol dogs (8.9). A biurrbcd diuretic 
and natriuretic response to volume xpansion i denervated 
cardiac anine preparations has been demonstrated (91, and 
it is appareni that the Iaterrui;tio:: nfaflerent neural fibers 
mediating, in part, volume homeostasis creates, a decrease in
the oppDsition of sympathetic renal stimulation. A new 
volume steady state develops that ranslates into fitdid reten- 
tion and altered cardiac loading condirions (?-a). it aiso ha? 
been slmvn f NJ that denervation f the heart causes myo 
cardial catecholamine !evcls to diminish as early as I week 
after autotransplantation in a imal modeis. This observation 
has also bees confirmed by analyzing biopsy specimens 
taken serially after heart ransplant inhumans (11). 
A variety G :l;hocardiographic te hniques have given us 
insight into the amtomic and functional chara.cteristics of the 
transplanted heart (20,22,23j. In studies performed when 
rejectilon is absent, ejection fraction remains within normal 
limits over at least a 4-year f&w-up period, $ut substaotial 
increases incardiac VO!P~ i.h dnd eMi-systolic Wall siiress are 
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.Sl!b P?9~:;-:i 
in t&e absence of inc 
ve~t~ic~~2~ diasto 
andi elevated left heart hihng :>ressures 2 
relate wiiii preoperative pulmonary ssure or vascular 
An a~~r~~~~ate increase in 
sity exercise, resulting fro 
reports. At mm-e intense exercise levels, k:rt rate and 
contractii.ty are augmented as well. prohabiy because of 
increasing circulating catechoiamines. 
lltilizing rest blood pool radionuciide aegisgraphp. “v’r- 
rani et al. 127) demonstrated that systohc ventricular perfor- 
mance uf the twnsplanted heart, assessed by measurement 
^ . * . 
oi i&t and left ventrtcular eJectton fracaons, ~~3s compara- 
ble to that of normal subjects. Resr peal: dia~totiz Sing we 
.n c I:..- “‘*CA a:1,d trme to peak diastolic AUK lakL ~~‘ii:.C ““-1% xoyr2i as well. 
hluring exercise. significant increas occurred ir: left and 
right ve:?tricular ejection fractions a aeak diasto!ic filling _ 
rcite, but peak ieft and right vcI. 7’~*~tric~u!ar ejeciion fractions 
were significaatly lower than those of normaJ s~.djects. It ca:! 
be concluded that heatr transpiant patients have mildly 
impairecj ventrkrlar function reserve that R@iiXS maximal 
exercise strew: it3 uncover. 
One !&racteristic of the deaervated tt~ ptankd heart 
withr,ut tonic vagal inpet is a h+h heart rate al rest (95 to I15 
$6 60 :o i0Cl bcats/min in ._ . normal subjects). The rate accel- 
erates more slowly than normal during exercise and tends to 
be iower at the same level of exercise thsn Is seem with the 
innervated heart (22). The rate does not respond to physio- 
logic stimc!i such 2:s carG?id sinus mal;sage or innervation- 
dependent pharmtirologic stimuii such as atropine. 
As suggested, heart transpian~ l recipients have diminished 
maximal exercise toierance compared ;ksith that of normal 
subjects, and this probabllv results fr@m subnsrmaJ ejection 
frac?ion and cardiac outpu: a ~gmeniation in response to 
,S --..n.,r,2 . . exercise as welt as an enaggcaat~~ lilb8cU+W ..A l~l.l_j..l__l :-...:.,.azn EP err@-ap.qr. 1. d’ac 
filling pressure during exercise (D-29). Elevated intracar- 
diac fdling pres,sure in the se?ting irf ncjrmal or reduced left 
ventricular vohtme suggests that the orthotopicaily trans- 
plant& he3fi functions QE a ventric?_rSar presswe-volume 
curve that is steeper than normal and shifted leftward. As 
previously suggested, this type of hemodynamic pidlk 
implies that the wntric!es are less compliant than normal, 
A\ noted in animal models of orthotopic hearc transpian- 
tation. human donor hear? cardirciorny *Viirh $,&st$Guefii 
art hotopic t~~~s~~a~tat~~~ creates both afTeren? 2nd e@ere 
cardiac denervztion (3.4.7). Afferent nerve i~te~~~~tion al- 
tcrs cardiovascular hor~eostasis by imp3irjng renin- 
angioiensin ai;io~tero~~_ _ -0 reg:;!ation and impeding the normal 
vasoregulatory respsnse to changing cardiac tilling pressure 
134. Furr:he:more. absence of 2Eerent signaling eklinarzs 
the subjective experience of angina pectoris during periods 
of ischemia w!. _ ‘2F’ Cardiac efferent innervation me 
pathetic and par3sympathetic neivous system e 
heart. The absence of vagahy mediated pa 
influences causes heart rate at rest to be higher and climi- 
mO,Ar ,&.A :-a..---- li,lll’i.l 99~ ~!~::uc::Lc CHi tile iiGtit 01 vagan I- --- --i $gaiai@ from the 
c&fa”l neri cw sys:em (22). Loss of autonomic i~~e~vat~~~ 
hlIlnts the usual rapid changes in eart rate and co~tract~~~ty 
seen during exercise, hypovok or vasQd~~ati~~ CM 2nd 
Ve ’ et ai. [tmpubhsbed observations]). 
A. . 2::s~ me clenervated csr+tnu._ bn __ Ah- araff 
~;gt lhrou 
Iniy0cCSUlu. ~-?--1.-t bet2 adrenergic receptors by ~~cuiaihg CE!F+ 
choiamines (34). 3dm&stration of beta-adrenergic biockrng 
drugs may be dcieterhous during stress &i2!IWlS. Verani et 
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al. (unpublished observations) characterized the effect of 
acute beta-adrenergir: blockade in heart ransplant patients. 
Beta-adrenergic blockade produced a decrease inventricular 
performance at rest in transplant patients and control sub- 
jects, characterized by lower values for stroke volume 
index, cardiac index and ejection fraction in both groups, 
with the changes generally similar except for a greater 
decrease in ejection fraction in the transplant recipients. 
This decrease was caused by a reduction in heart rate and, 
quite likely, contractility. As the ejection fraction decreased 
in the heart transplant patients, end-systolic volumes in- 
creased substantially. In the normal patients there was a 
reduction in heart rate because there was only a minimal 
reduction i ejection fraction and no change in end-systolic 
volume. These observations emphasize that in the dener- 
vated heart ransplant patient, circulating hormones appear 
crucial to maintain reasonable exercise performance. 
The response of the denervated heart to other forms of 
stress is also important to consider. In a canine model of the 
denervated heart, Tsakiris et al. (36) demonstrated that acute 
hypertension was wcli tolerated with only a slight decrease 
in cardiac output and a small increase in left ventricular 
end-diastolic pressure, but hypotension was less well toier- 
ated with minimal reflex increase in cardiac output because 
of little heart rate response. Mohanty et al. (37) demon- 
strated that barareflex-induced volume rcgu!ation after car- 
diac transplantation. s impaired. Volume unloading induced 
with a lower body negative pressure apparatus produced 
minimal reduction in forearm blood flow and only a slight 
increase inforearm vascular resistance, because orthotopic 
heart transplantation permits portions of the native atria with 
their accompal,,Yi --I ng sympathetic and parasympathetic inner- 
vation to remain. This‘ observation stigpsto that nerves 
arising in the ventricle rather than in the atrium or pulmo- 
nary vasculature constitute the afferent limb of this reflex. 
Furthermore, it has been suggested (21) that the inability to 
vasoconstrict blood flow to nonworking muscles plays a role 
in limiting the maxima! exercise capacity of heart ransplant 
patients. Scberrer et al. (38) have further suggested that he 
cyclosporine-induced hyperter+ aal,~ seen in heart ransplant 
recipients i associated with increased peripheral sympa- 
thetic nerve discharge and suggested that this effect of 
cyclosporine may be exaggerated in heart ransplant patients 
because ofcardiac denervation. 
There is evidence that reinnervation occurs in some 
patients late after orthotopic heart transplantation. It has 
been demonstrated by immunohistochemical technique that 
most human cardiac ailografts remain extrinsically dener- 
vated but appear to contain viable intrinsic nerve fibers (39). 
Memia-induced subjective chest pain (classic angina pet- 
tois) in heart ransplant recipients has been reported (35) 
and suggests hat some heart ransplant recipients have at 
!ust partid afferent reinnervation. A study by Stark et al. 
(35) demonstrated a tyramine-induced cardiac epinephrine 
release response indicative of reinnervation i  two patients 
with an&a wctoris xnd ailogtaft arteriopathy . Wil<on et al. 
(4O), in a study of norepinephrine r lease in patients i 
response totyramine and sustained handgrip, concluded that 
it was likely that sympathetic reinnervation commonly QC- 
curs late after transplantation but that he pattern of reinner- 
vation is extremely variab!e. How frequent and how physi- 
ologically significant such reinnervation is remains to be 
elucidated. 
~lectroca~~iog~ap~ic and 
Electrophysiologic Changes 
Serial eiectro~ardiogra~hi~ (ECC) changes have been 
noted in the transplant ndeed. the earliest 
of monitoring heart ra rejection utilized serial quan- 
tification of ECG voltage (41,42). It is generally acce 
the cyciosporine era that the sensitivity and specificity of 
e~ectro~~rd~~~raphy are not acceptable for diagnosis and 
surveillance of rejection. 
Electrocardiographic abnormalities, however, are fe- 
quently observed. Leonelli et al. (unpublished obsr-rvations) 
demonstrated that 73% of first postoperative ECGs evi- 
denced changes from normal, with a predominance of right 
bundle branch block. Patient or donor age, ischemic time 
and prior drug therapy did not differ significantly between 
transplant patients with normal or abnormal early postoper- 
ative ECGs. Electrocardiograms can undergo evolutionary 
changes during the initial posttransplantation h spit;! period 
and Ceonelli et al. (unpublished observations) also noted 
that patients with pro sive deterioration of conduction 
manifest by v~ideni~g S complexes or worsening of a 
preexisting conduction defect had a higher early mortality 
rate. 
Approximately 20% of heart ransplant patients demon- 
strate sinus node dysfunction with slow or no spontaneous 
depolarization a d these indivicruals charar,teristicaliy have 
junctional rhythms with lower rest heart rates than those of 
the majority of transplant recipients (usually ~70 beatslmin) 
(43). Sindss node dysfunction may be caused by ischemic 
injury during graft retrieval, by rejection or by ailograft 
arteriopathy. Further more, sinus node dysfunction has been 
described in patients who died early or late after cardiac 
transplantation (44) and some y matients require permanent 
pacemaker implantation for persistent sinus node dysfunc- 
tion ((43-45). In addition to the usua! indications for perma- 
nent pacemaker implantation, some programs recommend 
permanent pacing in heart transplant pat.ients with unex- 
plained recurrent syncope or near syncopc, particular?y in 
the setting of allograft arteriopatby, assinus node dysfunc- 
tion may be intermittent and diOiicult to document (44). 
Electrophysiologic stttd#,, ,>* L=.P ePrformed in heart ransplant 
patients (46,47) demonstrate that atrioventricuiar {AFyrj n&e 
conduction times are simii!ar to those of normal subjects, 
both at rest and during atrial pacing. AH and HV intervals 
are also normal. Usually, the AV node alters conductivity 
relative to the rate of stimuiatiou. This characteristic still is 
apparent in the denervated heart (47) but, whereas the 
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cbaaages OCCUE almost i~sta~~ta~2G~s~v in an innervated 
heart, tbey ‘re mm-2 time (several seconds) to occur in a 
transplante rt. Cokctively. observations such as these 
an being crittcal to the u 
function. 
atient are not com- 
to be either bradyarr 
noted, or tachycardias 
c, particulariy rn terms of ischemia- 
(489. There seems to be a low 
thmias in long-term sirivivors 
of both orthotopic and heterotopic heart t~a~~s~~antatio~ and 
most investigators would agree that the occurrence o 
tricular arrhythmias is most co manly associated wi 
ve~opme~t of al~ograft ar~erio~athy (49.50). Atrial arr~~yt~- 
rrtrast, are frequentiy associated with rejectton 
radyarrhythmias maj ako occur with coronary 
artery disease and should e considered in paiients complain- 
ing of nonspecific “weak” spells or presyncopal episodes. 
Sudden death in the absence of coronary artery disease or 
acute rejection is quite rare jn transplant recipients. 
i$fCf Of LhigS 19fZ the ~~~iiS~~~i~~~a’ Y sad 
Because of the existence of denervation, drugs affecting 
physiologic responds through autonomic nervous system 
stimulation are- not usually effective in the transplanted 
heart. For :nstance, since the efiect of atropine is mediated 
by a parasympatholytic mechanism. it does not speed the 
ventricular rate in bradycardia (5 I). Likewise, edropho~~um. 
a cholinesterase inhibitor, has 110 effect on heart rate (52), 
Sympathomimetic agents such as isoproterenoi that directly 
stimulate myocardiai receptors have the normai or expected 
etfects tin heart rate and contractility. 
Increased sensitivity of the denervated transplanted heart 
to parenterally administered beta-adrenergic agents such as 
isoproterenol has been noted (53). Exaggerated sensitivity to 
acetylchobne in denervated canine modeis also has been 
reported (54). Because acetylcholime and the endogenous 
nucleoside adenosine have similar cardiac eiectrophysio- 
logic &‘ects, Ellenbogen et ai. (55) used adenosine and 
demonstrated that the denervated donor sinus node had 
greater sensitivity to exogenous adenosine than did the 
recipient innervated node. Thus, care sf.ouid be exercised to 
prevent b~a~~arrhythmia if this agent is to be u.~:d durtng 
diagnostic scintigraphic study. 
Because the electrophysiologic effects of hgoxin are 
prrmdrily on sinoatrial and A’d nodes and mediated by way 
of the symmathetjc nervous system, this drug has iittle 
electrophysiologic activity in the transpknted heart (56). 
Tk inotropic effect of digoxin, which is not b~+rg mediated 
by way of the autonomic nervons system, seems to remain 
intact. 
blood pressure due to vasodilation and has also been shown 
erval (59). Vera- 
interval (59) and 
rate (60). These 
effects on conduction are very minor and do not cause 
substantive e~ectr~~bysi~~o~~c changes in the denervated 
heart. 
A’+” L lab rra!riuretk peptide is runally secreted by t 
heart and involved in volume homeostasis. It increases m 
response to atriai distension in normal humans 
with multiple pathcphysioiogic conditions. In 
plant patients, plasma atria! natriuretic peptid 
elevated (61) and, although atrial natriuretic 
’ creases with atria! stretch in tra~s~~a~t pat 
lgher than might be expected by atria! stretch alone. The 
mechanism responsible for the eievation has not been totally 
clarified. 
Several fktors may alter the function of the transplanted 
heart. Must important is rejection with its myocarditis, 
humoral antibody production and complement system acti- 
. . 
vation. These events directly impair cardiac contractth~~ and 
may also affect coronary blood flow. During acute rejection, 
coronary vascular reserve is compromised aQd varying de- 
grees of systohc and diastoiic ventricular dysfunction have 
been observed. Treatment of rejectiou often reverses these 
abnormaiities, resulting in improved graft function (62,633). 
However, biventricular diastoiic dysfunction hds been ob- 
served in some patients e! in after resoiution of histoiogic 
rejection. Other long-term changes apparent in the patient 
after transplantation include increased left ventricu!ar after- 
load and hypertrophy due to hypertension, which in tm 
contributes to aheration in bong-term heart function. 
kilograft arteriopatby is pa~ic~~ar~~ p:-evalent during 
long-term follow-up and also can c~Rtr~~~te to ~~ct~~~~a~ 
impairment. Systolic left ventricular dysfunctioci can occur 
in the setting of graft ischemic heart disease and CORHXWY 
angiographic fmdings define a high risk subgroup for subset 
quent cardiac even.,, tc such as acute myocardial infarction, 
heart failure resulting from myocardiai infarction, and sud- 
den cardiac death (64). 
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Heterotopic Newt Trunsplantation 
Heterotopic heart transplantation has been performed 
much less frequently than orthotopic procedures, compris- 
ing ~2% of all heart ransplant procedures inthe Registry of 
the International Society for Heart and Lung Transplanta- 
tion (65). The procedure is, nevertheless, important to 
consider because it may have a therapeutic niche (66,677). 
Generally, heterotopic procedures have been performed in
the setting of very elevated pulmonary artery pressure or 
when the donor size seems inadequate in relation to that of 
a potential recipient. The hemodynamic function of the 
heterotopic heart ransptant involves additional physiologic 
variables, uch as the contribution tooven!! cardiac output 
of the native heart and different loading conditions, particu- 
larly pulmonary hypertension. Because both donor and 
native hearts are beating in parallel, but not synchronously, 
hemodynamic assessment of relative contributions of native 
and donor hearts in these patients i  most JiBcult. Hetero- 
topic implants have been demonstrated to be capable of 
completely supporting a patient’s circulation when the na- 
tive heart becomes asystolic or develops ventricular fibrilla- 
tion (67). Clearly, this type of heart ransplant can provide 
hemodynamic support adequate enough to ameliorate many 
of the heart failure abnormalities noted in end-stage l ft 
ventricular dysfunction. Regression ofpulmonary hyperten- 
sion and elevated pulmonary vascular resistance an occur 
over several weeks, and seems imilar to the resolution seen 
in orthotopic heart ransplant recipients (66). 
Summary 
The transplanted heart is denervated, except as noted 
herein, and in the absence of rejection, coronary artery 
disease or hypertension, it performs in similar but not 
entirely identical fashion to that of normal hearts at rest. 
Diastolic dysfunction iscommon early and may recur at a 
late stage in some patients. Cardiac reserve during exercise 
is adequate but generally ess than normal. Augmentation f 
cardiac performance does occur and seems to restdt from 
endogenous elevation of catecholamines and changes in 
diastolic loading conditions. However, in view of preopera- 
tive functional limitations apparent in end-stage heart fail- 
ure, patients undergoing successful heart transplantation 
have a remarkable improvement i  cardirc performsnce. 
Recommendatioru 
The Task Force recommends that he following be under- 
taken by the transplant community: 
I, Develop evaluation standsuds for heart transplant 
recipients so tltat functional peri;ormance haracteristics at 
various times after heart ransplantation can be objectively 
quantified in uniform fashion and disabiiity due to graft 
ma!fimction identified. 
2. Develop a universal functionai classification f heart 
transplant recipients hat is more precise than the New fork 
Heart Association crtegories. These criteria should be base 2
on noninvasive measures ofsystolic and diastolic function as 
we!! as exercise capacity. 
3. Determine the relation to disability of functiona! ;er- 
formance characteristics after heart ransplantation. 
4. Encourage funding of clinical physiologic studies to 
develop methods toimprove function of the transplanted heart. 
Analyses of benefits after heart tra~s~la~tatio~ have 
overwhelmingly focused on survival. Because transplanta- 
tion is usual!y pe~~~~~e~ in patients with end-stage heart 
failure having a high probability of death within a short 
period of time, the merit of this operation in terms of 
conferring improved survival is now considered great; sur- 
viva! rates of 80% to 90% at 1 year and GO% to 70% at 5 years 
are to be expected (65,68). Whereas heart transplantation 
was previously considered an appropriate option only in 
patients unlikely to survive 6 months, patients today some- 
times are considered candidates for heart ransplantation if 
they have a 50% survival ikelihood at 24 months (691. It 
seems that as more patients are placed on waiting lists for 
heart ransplantation and waiting times lengthen, the acuity 
of illness of these patients may be lessening, as is addressed 
by Task Force 3. Assessing quality of life variables after 
transplantation, therefore, becomes extraordinarily impor- 
tant, particularly when comparing the physiologic omcome 
after transplantation with functional capacity possible after 
modern, aggressive pharmacologic ,nanagement of heart 
faiiure (69,701. !nsuch assessment it is crucial to remember 
that quality of life judgments are frequently subjective and if 
a patient’s premorbid quality of life is poor, it is unlikely to 
be significantly changed by a heart ransplant procedure. 
It is apparent that improvement IDquaiity of life after 
heart ransp!antation cart be dramatic Cur many persons who 
return to a productive working environment and more nor- 
ma! family unit. However, the residual psychologic trauma 
of suffering a devastating and near-fatal illness treated with 
an unusual operation cannot be dismissed lightl:~. Further- 
more, the ongoing and indefinite medical therapy required to 
maintain mmune tolerance ofthe graft can cause a variety of 
side effects as we!! as devastating complications. Living in 
fear of these problems urely takes its toll emotionally in
many patients. Patients may become depressed and grieve 
over ioss of a normal body image. Guilt can become appar- 
ent when patients recall that a healthy, usually young, 
person died to make the transplant procedure possible (71). 
Quality of life after heart ransplantation can be assessed 
both subjectively and objectively (72); simply listening to 
patients’ stories is important (71). Still, such variables as 
survival, overall health status, ability to return to work and 
functional capacity can serve as objective measures of 
quality of life. Subjective and more persona! measures might 
inciude a patient’s perception of his or her weii-being, 
happiness or general satisfaction with life. Of cowrse, such 
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uality of Life 
Indicators 
Objective 
Erupioyment (% of patients) 
Physically active f,% of patients) 
Subjective 
Life satisfaction [score)* 
Well-being (score)t 
Psychologic a&3 (score)* 
Outcome 
3? to 50 
ii0 to 85 
3.1 I (5.539 
II.11 (11.77)§ 
5.49 t5.68)6 
“Range of values I.0 to 7.0, where 7.0 = positive satisfaction. i 
values 2.1 to 14.7, where high score = positive well-being. *Range of vaiues 
1.0 to 7.0, where 7.0 = positive effect. §Values for the general population of 
the United States in parentheses. All data are from Evans (68,72). 
perceptions are clearly ~e~en~e~t on a patient’s preopera- 
tive personality matrix. Asse 
ranging, analyzing info 
programs inthe U.S. In this stu 
levels and functional rehabihtati cardiac tmns~~antat~o~ 
plantation Study, indeed, estimated that 80% to 85% ofsurviv- 
ing heart ransp?an? recinients are physically active (based on 
giobal measures of activity) and t WCs no 
different from that reported by kidney, liver or pancreas 
transplant recipients. Only 32% of patients were emp~~~yed 
after heart ransplantation, but this, again, is not d 
employment estimates after kidney transp!antation (31% to 
46%) or liver transplantation (10% to 47%). The report suggest5 
that because heart ransplant recipknts, are physically active 
and, theoretically, capable of working, barriers to emplayabii- 
ity are important in limiting ainful and meaningful empioy- 
ment. This opinion has been expressed sewhere as well (71). 
For example, mployers may be hesitant t,o hire heart rans- 
plant recipients, fearing compromised :;mployee health and, 
therefore, reliability. Aiso, insurers migtu adversely rate group 
health insurance holders when they hire transplant recipients, 
thus affecting employers’ hiring decisions. Evans (68,192) points 
out that patients undergoing solid organ transplantation have 
employment records imilar to those of others who have had 
serious diseases uch as myocardid infarction or cancer, 
suggesting: again. that lack of insurablity may correlate with 
lack; of employability. 
Zn fact, many subjective measures ofposttrai~~~~a~tat~o~ 
quality of life are similar to those reported for the U.S. 
population i general. Indeed, almost 90% of patients analyzed 
score af B 1.77. Furt 
patients rated their h 
some way from doing 
ed assistance in traveli 
blems restricted 7% to 
work. These data suggest that at least 50% of heart t~nsp~ant 
patients cot&I adequately petiorm emp!oy.ment tasks; how- 
ever, stightiy kss than 33% actuahy retun to the workplace. 
Many other factors are apparent when analyzing wily 
patkents do not return to work, including lack of desire to 
return to the same job, unemployment before lransplanta- 
tion, economic uncertainties and. as mentioned, employer 
reluctance torehire heart ram& It patients. Mated to this 
employment issue is the fact t:~at 63% of heart ransplant 
recipients are receiving medical disability benefits, whereas 
only 45% of kidney transplant patients receive such support 
@,72); howevet ) kidney recipnents arc gencrahy ounger. 
The United Kingdom Heart T~a~sp~a~t Study also assessed 
qurJity of life (73,74). OveraM, during evaiurrtion kfke he& 
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transplantation, ly 8% of patients rated quality of life 
“high,” whereas 67% studied 3 months after transplantation 
gave their life quality an equivalent “high” score. This report 
suggested that 84% of patients had problems at their job before 
transplantation c mpared with 50% of patients after transplan- 
tation, 94% had difficulties looking after their home before the 
procedure compared with 20% after the procedure and 84% 
had problems with their sex life before the procedure compared 
with 2% afterwards (all p < 0.01). 
This study used the Nottingham Health Profile Survey to 
quantify the health status of heart ransplant patients and 
compare it with that of nontransplant control subjects (74). 
Mean scores for the variables studied were similar at I and 2 
years after transplantation when compared with values in the 
“normal” population control groups, with the exception that 
transplant patients had more difficulty sleeping. Variables 
reported included physical mobility, pain, sleep, energy, 
social isolation and emotional reactions. 
Other Studies 
Analysis of outcome after heart transplantation in the 
Stanford program also indicated that transplant recipients 
achieve reasonable functional capacity and rehabilitation in 
consistent fashion (75-78). Negative changes noted in these 
patients after transplantation generally occurred with re- 
spect o the patient’s financial situation, physical appearance 
(self image) and sexual functioning (although the latter was 
not always a statistically significant observation). Again, it 
was pointed out that patients were discriminated against in 
the labor force. 
Further assessment of quality of life after orthotopic heart 
transplantation was reported by Bunzel et al. !79). In their 
study, patients were asked to evaluate postoperative im- 
provement or deterioration a d satisfaction with the level 
reached utilizing a scale quantifying nine distinct areas, 
inciudlng physical, emotional, mental, vocational, sexual, 
finarcial, leisure, partnership and overall qr;alIty of !ife. 
Again, distinct improvement i  almost all dimensions except 
patients* financial situation was reported. Improvement in 
physical status was ranked best. 
Fimm’ul Factors and Quality oJL$e After 
Heart Transpluntatim 
Because financial stress and difficulties adversely affect 
quality of life after hs:art transplantation, it is important to 
understand the cost of these procedures and payment mech- 
anisms. In 1988 dollars. the median heart ransplant proce- 
dure charge reported by Evans (68) in the National Trans- 
plantation Study was $91,570. This charge should be 
compared with $39,625 for kidney, $145,795 for liver and 
%134,881 for heart-iung transplants, but does not include 
charges incurred before the procedure or the long-term cost 
of follow-up care. These costs compare very favorably to 
expenses incurred in most devastating illnesses. Although 
today most private insurers cover heart transplantation, 
there is no certainty that reimbursement will be su 
pay charges. Still, the day of coverage denial because of an 
“experimental” label the operation carried seems to have 
ended when Medicare coverage was extended to include 
heart ransplantation. i deed, in 1985 only 55% of private 
insurers provided heart ransplant benefits, whereas 84% did 
in 1988 (68). Currently, amore prominent proble:n seems to 
be coverage caps that limit insurance payments nd, thus, a 
patient’s available resources. For example, only 72% of 
payers reimbursed 80% of hospital charges in 1988. Although 
Medicare provides c articipa heart 
transpiantation, the Group pay- 
ment is low, and coverage for medications i restricted. 
Furthermore, Medicaid coverage for heart ransplantation s 
not universal, with 22% of states not offering reimbursement 
for this service in 1990 (68). Long-term medication cost 
coverage isoften unavailable. Loss of insurance benefits or 
a prohibitive rise in premiums can occur after trans 
tion as well, but data quantifying this problem seem unavail- 
able. It is not surprising, therefore, that patients report a 
negative impact on their quality of life precipitated by 
disease-generated financial impecunity. 
A stable financial situation iswhat most cardiac transplant 
patients believe to be required to have an acceptable quality of 
life (80,81). Therefore, returning to work after heart ransplan- 
tation is quite important. The study of Meister et al. (80) 
reviewed the data on 40 heart ransplant patients with respect 
to their eturn to work status. Patients were classified into four 
groups: those who were able to return to work (32%), those 
who were retired (25%), those who were medically disabled 
(7.5%) and those who were termed “insurance disabled” 
(36%). The latter patients were those who could have gone 
back to work but did not because offinancial limitations. They 
were dependent ondisability income or government-subsidized 
health care, and return to work would cause them to lose 
disabiiity income or heahh care benefits. These patients are 
usually considered medically uninsurable by potential new 
employers and therefore cannot hope to earn enough money to 
cover medical costs. Thus, they remain disab!:d to continue 
their health care benefits. 
Further insight into sociai rehabiiitation a d likeilh~~d of 
returning to work after heart ransplantation was provided 
by Paris et al. (88). Of 250 patients at seven heart ransplant 
centers from different geographic regions in the U.S., 45% 
were employed, 36% unemployed, 13% medically disabled 
and 6% retired, The majority of employed patients had 
returned to their previous workplace (87%). Of the unem- 
ployed, only 16% had made job applications and 63% had no 
pians to seek further employment. Variables predicting 
!ike!ihood of not returning to work included the length of 
medical disability before transplantation, the patient’s per- 
ception of being physlcal!y unable to work and the potential 
loss of health insmanGe or disability income. 
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with heart failure has been c
It has been suggested tiat deniai serves a protective 
adaptive fn~ctio~ inheart rafisplant recipients. 
Shapiro and Kornfeld (86) reported similar observations 
but emphasized the frequency of postoperative ~sycb~atr~c 
disorders and psychosocial difficulties. Intheir study, 51% of 
patients bad an affective illness c 
lability, i~~ta~lity and grandiosity. 
cuities, noted in I I%, may have been 
administration. Anxiety disorders were also frequent (noted 
in 26% of the patients), but they usually were not persistent 
or debilitating. Delirium was noted posioperatively in 4%. 
Also observed with some frequency were sexual dysfunction 
and an inability to return to the work force. 
Tabler and Frierson (87) expanded on sexual concerns 
patients have after heart ransplantation. These difficulties 
‘vere generally related to the psychologic mp:act of altered 
roles ad responsibilities, body image concerns, loss of 
auiowomj; with adverse ffec ts of. self-esteem; physiologic 
effects of medication with respect o sexual functioning, 
decreased libido, 1:hanges in mood, performance anxiety and 
residual fear of di:ath. It was believed that identification f 
these issues in any specific patient with appropriate counsel- 
ing and education wou!d reduce complaints. 
Pediatric Patients 
Few data are available assessing quality of life in pediatric 
heart ransplant recipients. Starnes et al. (88) indicated that 
growth delay was observed in a few patients Cl0 years of 
age but that rehabilitation ccurred in all patients who were 
dicrhsged &?rn the hospital. All survivors ire their study Xl<___ 
were said to be active -without physical limitations orrestric- 
tions. Psychosocial evaluation ofa small group of pediatric 
transplant patients utilizing the Personality Inventory for 
Children, the Eyberg Child Behavior Inventory and other 
uate in their series of 
cult to quantify precisely, 
tkat patients’ lives are vastly 
lantation, ot only in terms of 
ant and very worthw 
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Improvements in immunosuppression and recipient selec- 
tion have been associated with .&eased short- and long- 
term survival rates with heart ransplantation. A number of 
compkations, however, do occur after heart ra~s~~antatio~ 
(I), most of which can be traced to relative inadequate or
excessive dosing or intrinsic properties of immunosuppres- 
sive medications. The following section is a brief overuiew 
of these complications. 
